Click here to register for May 14 investor webcast
Company plans to file its Earnings Report on May 14, 2024 on Form 10-Q for the quarter ended March 31, 2024
Read More
U.S. FDA has informed Moderna that due to administrative constraints, the agency will not complete its review of mRNA-1345 by the PDUFA date of May 12, 2024
Agency has indicated it expects to complete the review by end of May
Read More